ASK1, which was known to participate in colon and skin tumourigenesis, could increase the expression of cyclin D1 through AP‐1 activation and cyclin D1 could up‐regulate ASK1 via the Rb‐E2F pathway in GC to stimulate tumour growth 32. Here, MAP3K5 is linked to gastric cancer.